Are We Democratizing AI In Healthcare Or Just Shifting The Burden?

The Consumer Technology Association recently convened Health Week, a summit of health policymakers, digital consumer brands, academics, entrepreneurs and investors to debate the future of medicine and artificial intelligence.

Rene Quashie, Vice President of Digital Health at CTA, opened the event with a personal experience revealing how ChatGPT was instrumental, if not insistent, in helping him seek urgent medical attention. The tool later proved more helpful than his physician in helping him navigate a prolonged recovery. Quashie highlighted new CTA research showing 41 percent of consumers now incorporate AI and/or social media into their non-emergency healthcare journeys, with AI emerging as the preferred digital source. His remarks framing AI as a superior alternative to our “idealized version of healthcare” set the stage for panels like “Should AI Be Allowed to Practice Medicine?” and “The AI Divide: Who Benefits and Who Gets Left Behind?”

In the first debate, American Medical Association CEO John Whyte expressed discomfort with AI operating absent physicians and cited the inaccuracy of AI-based diagnostic tools like blood pressure cuffs in retail kiosks. Marc Paradis countered, “There is nothing magical about being human,” arguing that we unfairly measure AI against the world’s best doctor rather than the deficient care most people actually receive. Laura Adams, a National Academies of Sciences, Engineering, and Medicine (NASEM) expert, noted, “Economics will decide who gets to do this. What does it mean for the patient and where can the tool sit most easily in the patient’s path?” The discussions, while provocative, did address concerns about access. Will these game-changing technologies be democratized for everyone, regardless of zip code and income, or only a few?